Is Corporate America's Debt Binge A Ticking Time Bomb?
Record-low interest rates have led corporations like Apple and GM to load up on debt, but Morgan Stanley doesn't think massive corporate bond issuance is a sign of peril for the equity market.
View ArticleBe Careful Who You Listen To
A look at how the historical odds favor equities and one of our favorite stock picks.
View ArticleFor 2016 Stocks, The Only Thing To Fear Is Fear Itself
A year of falling uncertainty should progressively boost stocks.
View ArticleU.S. Government Deficit Is Rising Again
The national debt and deficit are two of the greatest challenges facing the next generation of Americans. Unless we act soon, it may be too late!
View ArticleIBM Watson Imaging Collaborative Adds 16 Health Systems, Tech Firms
IBM Watson Health is forming a 16-member international imaging collaborative of health systems, academic medical centers and imaging technology companies to identify healthcare’s big problems in...
View ArticleMerck Results Underscore Need To Go Big Or Go Home In Diabetes Market
Looking at the earnings posted by Merck & Co. (MRK), I could not help but compare and contrast them with what Sanofi (SNY) said this morning. Like Sanofi had with Lantus, Merck has a...
View ArticleWhen Boundless Optimism Meets Medtech Anything Seems Possible
This is a study in optimism. Howard Leonhardt successfully developed a medical device and sold it to Medtronic. Now he's hoping to repeat that success multiple times simultaneously while launching a...
View Article3 Dividend Growth Stocks To Buy, 4 To Sell By September
Vanguard just closed its most popular dividend fund to new money. If you’re not already in, I'm afraid you’re out of luck. But I’ve got a backdoor way to duplicate – and even best – its winning income...
View ArticleMDT May 2017 Options Begin Trading
Investors in Medtronic PLC (NYSE: MDT) saw new options begin trading today, for the May 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time...
View Article21st Century Cures Act: Pork Or Promise?
This month is pivotal for passage of the #CuresNow, or 21st Century Cures Act, passed by the House in 2015 and now being considered by the Senate. If not passed now, it will probably languish, as the...
View ArticlePfizer Partners With IBM Watson To Advance Cancer Drug Discovery
IBM Watson Health and drug maker Pfizer have formed a relationship to accelerate drug discovery in “immuno-oncology” using the computer giant’s artificial intelligence system.
View ArticleAbbott's St. Jude Deal Aligns With Shift To Value-Based Care
The Federal Trade Commission’s approval of Abbott Laboratories’ $25 billion purchase of St. Jude Medical helps the larger company cope with value-based care and bundled payments to doctors and hospitals.
View ArticleMomentum Builds To Expand Medicare's Telehealth Coverage
Rare bipartisan healthcare legislation has emerged in the U.S. Senate to broaden access to telehealth services for seniors covered by Medicare insurance. The Telehealth Innovation and Improvement Act...
View ArticleSenate Health Bill's Only Win May Be Tax Relief To Device Makers
The tax on medical device sales is perhaps the least objectionable in all of the amendments the Republican-led U.S. Senate is considering this week.
View ArticleIntuitive Surgical Beats Expectations, Driven By da Vinci System
Intuitive Surgical again beat revenue and earnings expectations with the help of its da Vinci robotic surgical systems when it reported its second quarter performance after the market closed Thursday.
View ArticleHow To Build A Portfolio Of Aristocrats With Dividends Every Month
Shareholders in dividend-paying stocks received nice raises in 2018. Indeed, for 2018, net dividends rose $58.4 billion, compared to a gain of $37.1 billion in 2017, explains dividend expert Chuck...
View Article
More Pages to Explore .....